FGF2 and melanoma: Activated fibroblasts also affect melanoma drug resistance development among others through the production of hepatocyte growth factor (HGF), basic fibroblasts growth factor (bFGF), and neuregulin 1, which support cell proliferation and tumor growth [10, 12, 13].